Latest news

Classic list

Globally incubate standards compliant channels before scalable benefits. Quickly disseminate superior deliverables whereas web-enabled applications.

September 12, 2023 Short Course

18-22 September 2023

We recognise that cancer is a worldwide problem and that global collaborations will likely provide the best solutions. Since 2018, the Cancer Research UK Cambridge Institute (CRUK CI) and the Uganda Cancer Institute (UCI) have been working together to share knowledge and resources.

We are pleased to announce that this year we will be running a Summer School in Kampala, to build on the success of the joint Summer Research Programme.

Created in collaboration with Dr Nixon Niyonzima, Head of Research and Training at the UCI, and Dr Paul Katongele, Prof Benon Asiimwe and Dr David Kateete at Makerere University, the Summer School is designed to reach a wide audience and is open to both staff and students.

Between 18-22 September 2023, researchers from the CRUK CI will deliver 5 days of lectures and practical workshops at the Department of Immunology and Molecular Biology at Makerere University, demonstrating state-of-the-art technologies and concepts, all designed to align with ongoing research projects at the UCI.

To attend any of these lectures or workshops, you must register to attend. Places will be assigned on a first come, first served basis.

Read More >>>


September 6, 2023 Public Talk

We are delighted to invite you to the upcoming educational webinar hosted by the European, Middle Eastern & African Society for Biopreservation and Biobanking (ESBB) titled “Biobanks in Africa: Unlocking Biotech Potential – A Ugandan Edition.” This engaging event will provide valuable insights into the vital role of biobanks in the African context, with a special focus on Uganda.

Date: 19 September 
 15:00 CEST
Register Here.

Our distinguished speakers, Bonginkosi Duma and Sharley Melissa Aloyo, are experts in the field of biobanking and will share their knowledge and experiences, shedding light on the significance of high-quality biospecimens in the development and evaluation of diagnostic tests, as well as the biotech potential within Uganda’s biobanking landscape.

This webinar is an excellent opportunity for researchers, healthcare professionals, biobanking enthusiasts, and anyone interested in the pivotal role biobanks play in advancing healthcare and biotechnology.

Mark your calendar for September 19th at 15:00 PM CEST – we eagerly look forward to your participation!


July 29, 2023 Public Talk
The Chair, Department of Immunology and Molecular Biology invites you to be part of  Prof. Christina Lancioni’s Immunology talk scheduled for August 8th 2023.
Below are the details and zoom link for this event
Dr. Christina Lancioni is an Associate Professor in the Department of Pediatrics at Oregon Health and Science University in Portland, Oregon, USA. Dr. Lancioni received her medical education at the University of Pennsylvania, completed her Pediatric Residency at Children's National Medical Center in Washington DC., and her training in Pediatric Infectious Diseases at Case Western Reserve University. She is a physician-scientist, providing clinical care to children hospitalized with severe infectious diseases, as well as the principal investigator of a NIH-funded translational immunology laboratory. Her current research focuses on the intersections between early life immunity and vulnerability to infectious diseases, specifically Tuberculosis, as well as the role of nutrition in shaping pediatric immunity. Dr.
Lancioni has collaborated for over 15 years with Ugandan-based investigators on studies focusing on the immunobiology of Tuberculosis, as well as several recent studies focusing on identifying determinants of survival for infants hospitalized during the first 2 months of life.
Title: Interactions between Nutrition, environmental exposures, and Immunity in early life and their consequences for child health.

Date: Tuesday, 8th August 2023

Time: 8:00 am-10:00 am
Venue: Mak-CHS Microbiology laboratory Lecture room and online
Speaker: Prof. Christina Lancioni, MD
    Meeting ID:91892731204

Password: 246295

Attendance: Undergraduate and postgraduate students, clinicians, researchers

Chair: Dr.Obondo J.Sande, PhD


June 15, 2023 Public Talk

The iTech Project, Makerere University Hospital invites you to a Talk on Advances in Imaging and Clinical Application in Obstetrics;

The talk will be given by Prof. Aris T. Papageorghiou, an Academic, Clinician-Scientist, and Inventor. He is an expert in maternal-fetal medicine with special interests in global maternal and perinatal health, fetal growth and development, pre-eclampsia, ultrasound screening, invasive and non-invasive prenatal diagnosis, and fetal therapy

Topics: Advances in Imaging and Clinical Application in Obstetrics

Date: Tomorrow Thursday 15th June 2023

Time: 9:30 am

Venue: Online & Kawempe National Referral Hospital

Join via Zoom – See the link below;

Moderator: Prof. Josephat Byamugisha, Director, Makerere University Hospital


May 14, 2023 Global News

An open-source public database for all cough TB recordings which future researchers and the public can utilise and develop more tools that can address the TB burden through cough sounds.

CageTB has a focus in Automated smartphone-based cough audio classification for rapid tuberculosis triage testing (Cough Audio triaGE for TB) CAGE-TB.


May 14, 2023 Global News

Dr. Wayengera successfully developed a rapid diagnostic kit for Ebola. We are sure, under his leadership, Uganda had a response to COVID19 that is effective and efficient. He also came up with a Solution name: Pan-Filovirus Rapid Diagnostic Test Ebolavirus and Marburgvirus cause rare but fatal viral haemorrhagic fevers (VHFs) in remote villages of equatorial Africa. Both filovirus VHFs are highly infectious with potential for urban, regional and global spread. Early detection is important for VHFs epidemic prevention and control.

Whereas two rapid diagnostic tests (RDTs) have emerged on the scene for Zaire ebolavirus (EBOV), RDTs for other Ebolavirus species that cause VHFs in humans, such as Sudan ebolavirus-SUDV, Bundibugyo ebolavirus-BDBV, Tai Forest ebolavirus-TAFV and Marburgvirus-MARV are missing. Given the similarity of symptomatology among VHFs and other infectious diseases, it is clear that RDTs to combat filovirus VHFs are needed.


May 14, 2023 Global News

Prof. Moses Joloba was recognized by CDC Global for his effort to fight tuberculosis in Africa in the year 2022. Prof. Moses Joloba, Director of Uganda’s Nat’l. TB Reference Laboratory, has built capacity for #TB diagnosis & surveillance for 25+ years. His leadership was vital in the GeneXpert platform expansion, which helps diagnose drug resistant TB.


May 14, 2023 Annual Report
It is with great pleasure that I present to you the second Annual Report of the Makerere University Biomedical Research Centre (MakBRC), which captures our performance for the year 2021- 2022. The Centre is committed to demonstrating integrated thinking and value creation for our stakeholders, as well as sustainability for the future as we work towards championing biomedical sciences. The MakBRC Board of Directors remains committed to providing an enabling corporate governance framework and supporting the company to achieve its five-year strategic plan. I take this opportunity to reassure our stakeholders that the MakBRC is a center of sound repute, premised to build on its achievements. Our highly experienced leadership coupled with a competent team of staff members will always strive to deliver exceptional performance against the set targets. On behalf of the Board of Directors, I thank all our stakeholders for supporting the organization. I equally thank the management and staff for innovatively transforming the company to what it is today.

In short words

MakBRC is a Ugandan registered Not-for-Profit Organization fully owned by Makerere University established within Makerere University College of Health Sciences.


Please subscribe to our Newsletter.

    Copyright by MakBRC ©2023. All rights reserved.